Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades22,458
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Company
Research
AZN Company
Timeline
Share Price Information for Astrazeneca (AZN)
Last checked at -
Last checked at 
Intraday Astrazeneca Share Chart
Astrazeneca News
Health Rounds: Lilly blood thinner tops AstraZeneca's for heart procedure patients with diabetes
Nov 14 (Reuters) - Blood-thinning drugs that doctors often prescribe interchangeably after procedures to reopen narrowed heart arteries don’t work e...
DIRECTOR DEALINGS: Springfield Properties chair banks GBP2.6 million
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately...
LONDON BROKER RATINGS: RBC and Deutsche like SSE; Barclays likes Wizz
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:
UK's FTSE 100 hits record close as US shutdown nears end
FTSE 100 up 0.1%, nearing 10,000 mark *
FTSE 100 closes at record high on rate cut bets; AstraZeneca shines
FTSE 100 up 1.2%, closes near 10,000 mark *
LONDON BROKER RATINGS: Jefferies cuts Croda; Deutsche cuts Ashmore
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
AstraZeneca hits record high, cements lead as UK's biggest stock
Nov 11 (Reuters) - Shares in AstraZeneca rose past their September 2024 peak on Tuesday, hitting a fresh record high and cementing the company's pos...
AstraZeneca says Baxdrostat reduces 24-hour systolic blood pressure
(Alliance News) - AstraZeneca PLC on Sunday announced results from the phase 3 trial of its Baxdrostat treatment which showed a statistically signific...
Follow the stocks
